Persistence of tolerance to methamphetamine-induced monoamine deficits.

MLA

Danaceau, Jonathan P., et al. “Persistence of Tolerance to Methamphetamine-Induced Monoamine Deficits.” European Journal of Pharmacology, vol. 559, no. 1, Mar. 2007, pp. 46–54. EBSCOhost, https://doi.org/10.1016/j.ejphar.2006.11.045.

APA

Danaceau, J. P., Deering, C. E., Day, J. E., Smeal, S. J., Johnson-Davis, K. L., Fleckenstein, A. E., & Wilkins, D. G. (2007). Persistence of tolerance to methamphetamine-induced monoamine deficits. European Journal of Pharmacology, 559(1), 46–54. https://doi.org/10.1016/j.ejphar.2006.11.045

Chicago

Danaceau, Jonathan P, Cassandra E Deering, Jayme E Day, Stacy J Smeal, Kamisha L Johnson-Davis, Annette E Fleckenstein, and Diana G Wilkins. 2007. “Persistence of Tolerance to Methamphetamine-Induced Monoamine Deficits.” European Journal of Pharmacology 559 (1): 46–54. doi:10.1016/j.ejphar.2006.11.045.